PolyPhotonix

📍 Sedgefield, United Kingdom🗓 Founded 2009👥 13 employees💰 Last funded Jan 2025
PolyPhotonix is a biophotonic research and development company that designs, develops and manufactures non-invasive photonic based medical devices. Established in 2009 in the North East of England, the company is focused on light therapy treatments for macular eye disease and has successfully brought its first medical device through clinical trials to market. The Noctura 400 Sleep Mask is a transformational treatment for Diabetic Retinopathy and Diabetic Macular Oedema, which are serious complications of diabetes and are the principal causes of blindness among people of working age in the UK. For more details visit our product website www.noctura.com. Contact us on: +44 (0) 1740 625 555 Email: enquiries@polyphotonix.com Website: www.polyphotonix.com
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in PolyPhotonix?
PolyPhotonix has 1 investors on record on gritt.io.
When did PolyPhotonix last raise funding?
The most recent investment in PolyPhotonix recorded on gritt.io was in January 2025.
When was PolyPhotonix founded?
PolyPhotonix was founded in 2009.
What industry is PolyPhotonix in?
PolyPhotonix operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is PolyPhotonix based?
PolyPhotonix is headquartered in Sedgefield, United Kingdom.